Cargando…

Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab

It is well documented that patients affected by rheumatoid arthritis (RA) have distinct susceptibility to the different biologic DMARDs available on the market, probably because of the many facets of the disease. Monocytes are deeply involved in the pathogenesis of RA and we therefore evaluated and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talmon, Maria, Percio, Marcella, Obeng, Joyce Afrakoma, Ruffinatti, Federico A., Sola, Daniele, Sainaghi, Pier Paolo, Bellis, Emanuela, Cusinato, Stefano, Ianniello, Aurora, Fresu, Luigia G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987802/ https://www.ncbi.nlm.nih.gov/pubmed/36877690 http://dx.doi.org/10.1371/journal.pone.0282564

Ejemplares similares

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
por: Benucci, Maurizio, et al.
Publicado: (2017)

Different Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior
por: Brambilla, Marta, et al.
Publicado: (2022)

The Complex Journey of the Calcium Regulation Downstream of TAS2R Activation
por: Talmon, Maria, et al.
Publicado: (2022)

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

Subcutaneous Abatacept vErsus Intravenous Abatacept: A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
por: Genovese, M C, et al.
Publicado: (2011)

Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience
por: Maccora, Ilaria, et al.
Publicado: (2022)

Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates
por: Diep, Laetitia, et al.
Publicado: (2022)

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity
por: Takahashi, Nobunori, et al.
Publicado: (2013)

Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis
por: Derambure, Céline, et al.
Publicado: (2020)

Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA—a retrospective, exploratory cohort study
por: Bouman, Chantal A M, et al.
Publicado: (2018)

Is tumor necrosis factor genotype (TNFA2/TNFA2)a genetic prognostic factor of an unfavorable outcome in IgA nephropathy?
por: Lee, E. Y., et al.
Publicado: (2001)

Molluscum contagiosum eruption during therapy with methotrexate and abatacept: A clinical and dermoscopic case study
por: Taviti, Franca, et al.
Publicado: (2022)

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
por: Guyot, Patricia, et al.
Publicado: (2011)

Association of TNFA Promoter Region Haplotype in Behçet's Disease
por: Park, KyungSook, et al.
Publicado: (2006)

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry
por: Harrold, Leslie R., et al.
Publicado: (2016)

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis
por: Huoponen, Saara, et al.
Publicado: (2019)

Paracrine Shear-Stress-Dependent Signaling from Endothelial Cells Affects Downstream Endothelial Function and Inflammation
por: Bertani, Fabio, et al.
Publicado: (2021)

Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
por: Westhovens, R, et al.
Publicado: (2009)

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
por: Hirabara, Shinya, et al.
Publicado: (2014)

The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis
por: Tada, Yoshifumi, et al.
Publicado: (2016)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
por: Suzuki, Takako, et al.
Publicado: (2018)

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
por: Gottenberg, Jacques-Eric, et al.
Publicado: (2019)

Tocilizumab Attenuates Anti-neutrophil Cytoplasmic Antibody-associated Nephritis Occurring during Abatacept and Adalimumab Therapy for Rheumatoid Arthritis
por: Yoshimura, Yusuke, et al.
Publicado: (2022)

TNFA and IL10 Gene Polymorphisms are not Associated with Periodontitis in Brazilians
por: Moreira, P. R, et al.
Publicado: (2009)

Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment
por: Westhovens, R, et al.
Publicado: (2004)

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
por: Narváez, Javier, et al.
Publicado: (2015)

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
por: Balza, Enrica, et al.
Publicado: (2006)

Mucosal infection rewires TNFɑ signaling dynamics to skew susceptibility to recurrence
por: Yu, Lu, et al.
Publicado: (2019)

Regenerative Potential of A Bovine ECM-Derived Hydrogel for Biomedical Applications
por: Di Francesco, Dalila, et al.
Publicado: (2022)

Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)
por: Kaneko, Yuko, et al.
Publicado: (2016)

Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
por: Emery, Paul, et al.
Publicado: (2023)

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
por: O’Mahony, Alison, et al.
Publicado: (2018)

Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease
por: Gnjec, Anastazija, et al.
Publicado: (2008)

Reversible depressive effect of TNFa on a model of isolated perfused rat heart
por: Nguyen, BV, et al.
Publicado: (2013)

Mecp2 regulates tnfa during zebrafish embryonic development and acute inflammation
por: van der Vaart, M., et al.
Publicado: (2017)

Missense variants in the TNFA epitopes and their effects on interaction with therapeutic antibodies—in silico analysis
por: Ahsan, Tamim, et al.
Publicado: (2022)

Polylysine Enriched Matrices: A Promising Approach for Vascular Grafts
por: Fusaro, Luca, et al.
Publicado: (2020)

Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: Addressing treatment outside the current NICE guidance
por: Chiu, Yee, et al.
Publicado: (2012)

Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
por: Witte, Torsten
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dn258a60g2130kem79ajocr9bp